Y, K., & C, X. (2018). Transferrin receptor-targeted HMSN for sorafenib delivery in refractory differentiated thyroid cancer therapy. Dove Medical Press.
Style de citation Chicago (17e éd.)Y, Ke, et Xiang C. Transferrin Receptor-targeted HMSN for Sorafenib Delivery in Refractory Differentiated Thyroid Cancer Therapy. Dove Medical Press, 2018.
Style de citation MLA (8e éd.)Y, Ke, et Xiang C. Transferrin Receptor-targeted HMSN for Sorafenib Delivery in Refractory Differentiated Thyroid Cancer Therapy. Dove Medical Press, 2018.
Attention : ces citations peuvent ne pas être correctes à 100%.